Literature DB >> 15306225

Structural and electrical ventricular remodeling in rat acute myocarditis and subsequent heart failure.

Yuko Wakisaka1, Shinichi Niwano, Hiroe Niwano, Junko Saito, Tohru Yoshida, Shoji Hirasawa, Hideaki Kawada, Tohru Izumi.   

Abstract

OBJECTIVE: We reported that experimental autoimmune myocarditis (EAM) rats showed dramatic changes in ventricular action potential and enhanced arrhythmogenicity in the acute phase, but mechanisms for this are still unclear. To investigate the mechanisms of cardiac remodeling in acute myocarditis and subsequent heart failure, physiological and molecular changes were evaluated along the time course of EAM.
METHODS: Six-week-old Lewis rats were immunized with porcine cardiac myosin. On days 14, 21, 35 and 60 after immunization, histology, hemodynamics and electrophysiological parameters (i.e., effective refractory period (ERP), monophasic action potential duration (MAPD) and PVC inducibility) were evaluated and compared with control rats. After these studies, the expression levels of Kv(+) and L-Ca(2+) channels, ion transporters and BNP expressions in the left ventricle were examined by quantitative real time RT-PCR and Western blot analysis.
RESULTS: EAM rats showed acute myocarditis with massive infiltration of the mononuclear cells on days 14 and 21. Subsequently, a chronic dilated cardiomyopathy (DCM)-like structural change was observed on day 60. Hemodynamic parameters were worse in EAM than controls. ERP and MAPD were longer in EAM than controls, with a peak on day 21, which was parallel to PVC inducibility. mRNA levels of Kv4.2, Kv1.5, KChIP2, frequenin and SERCA2a, and the protein levels of Kv4.2 and Kv1.5, were reduced, especially in the acute phase.
CONCLUSIONS: The initial reduction of Ito-related molecules, such as the expression levels of Kv4.2, 1.5, frequenin and KChIP2, and the prolongation of MAPD are considered to be a key mechanism of ventricular remodeling and cause the characteristic clinical findings in EAM in the acute inflammatory phase and chronic DCM phase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15306225     DOI: 10.1016/j.cardiores.2004.04.020

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  10 in total

Review 1.  Rodent models of heart failure: an updated review.

Authors:  A C Gomes; I Falcão-Pires; A L Pires; C Brás-Silva; A F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

2.  FGL2 knockdown improves heart function through regulation of TLR9 signaling in the experimental autoimmune myocarditis rats.

Authors:  Zhenzhong Zheng; Longhui Yu; Yujing Wu; Hao Wu
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

3.  Computational Identification of Ventricular Arrhythmia Risk in Pediatric Myocarditis.

Authors:  Mark J Cartoski; Plamen P Nikolov; Adityo Prakosa; Patrick M Boyle; Philip J Spevak; Natalia A Trayanova
Journal:  Pediatr Cardiol       Date:  2019-03-06       Impact factor: 1.655

4.  Immune tolerance to cardiac myosin induced by anti-CD4 monoclonal antibody in autoimmune myocarditis rats.

Authors:  Qing-Qing Wang; Yu-Lin Wang; Hai-Tao Yuan; Feng-Qin Liu; You-Peng Jin; Bo Han
Journal:  J Clin Immunol       Date:  2006-05-02       Impact factor: 8.317

5.  Protein Kinase C-Mediated Hyperphosphorylation and Lateralization of Connexin 43 Are Involved in Autoimmune Myocarditis-Induced Prolongation of QRS Complex.

Authors:  Chunlian Zhong; Huan Zhao; Xinwen Xie; Zhi Qi; Yumei Li; Lee Jia; Jinwei Zhang; Yusheng Lu
Journal:  Front Physiol       Date:  2022-03-28       Impact factor: 4.566

6.  Angiotensin II-mediated up-regulation of connective tissue growth factor promotes atrial tissue fibrosis in the canine atrial fibrillation model.

Authors:  Michiro Kiryu; Shinichi Niwano; Hiroe Niwano; Jun Kishihara; Yuya Aoyama; Hidehira Fukaya; Yoshihiko Masaki; Tohru Izumi
Journal:  Europace       Date:  2012-03-27       Impact factor: 5.214

7.  Effect and mechanism of fluoxetine on electrophysiology in vivo in a rat model of postmyocardial infarction depression.

Authors:  Jinjun Liang; Xiaoran Yuan; Shaobo Shi; Fang Wang; Yingying Chen; Chuan Qu; Jingjing Chen; Dan Hu; Bo Yang
Journal:  Drug Des Devel Ther       Date:  2015-02-10       Impact factor: 4.162

Review 8.  What Is the Arrhythmic Substrate in Viral Myocarditis? Insights from Clinical and Animal Studies.

Authors:  Gary Tse; Jie M Yeo; Yin Wah Chan; Eric T H Lai Lai; Bryan P Yan
Journal:  Front Physiol       Date:  2016-07-21       Impact factor: 4.566

Review 9.  Sizing up models of heart failure: Proteomics from flies to humans.

Authors:  Viola Kooij; Vidya Venkatraman; John Tra; Jonathan A Kirk; Janelle Rowell; Anna Blice-Baum; Anthony Cammarato; Jennifer E Van Eyk
Journal:  Proteomics Clin Appl       Date:  2014-06-25       Impact factor: 3.494

10.  Up-regulation of miR-195 contributes to cardiac hypertrophy-induced arrhythmia by targeting calcium and potassium channels.

Authors:  Lina Xuan; Yanmeng Zhu; Yunqi Liu; Hua Yang; Shengjie Wang; Qingqi Li; Chao Yang; Lei Jiao; Ying Zhang; Baofeng Yang; Lihua Sun
Journal:  J Cell Mol Med       Date:  2020-05-28       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.